Pharmahungary Group as a Hungarian SME is ready to join Horizon Europe grant applications with innovative preclinical and clinical R&D services.
Pharmahungary Group Clinical Director emphasized the importance of the new European Union legislation on clinical trials during her lecture
National Heart Program: successfully closed – significant advances
Pharmahungary Group – Horizon Discovery Press Release
Pharmahungary Group joins international inflammation consortium